Tiptree Inc is an insurance-specialty business based in the US. Tiptree shares (TIPT) are listed on the NASDAQ and all prices are listed in US Dollars. Tiptree employs 1,372 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Active traders
Our top pick for
Beginners
Our top pick for
Building a portfolio
| Latest market close | $13.79 |
|---|---|
| 52-week range | $4.75 - $17.25 |
| 50-day moving average | $14.09 |
| 200-day moving average | $11.45 |
| Wall St. target price | N/A |
| PE ratio | 8.7516 |
| Dividend yield | $0.16 (1.19%) |
| Earnings per share (TTM) | $1.53 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $13.79 from 2022-01-14
| 1 week (2022-01-10) | 4.23% |
|---|---|
| 1 month (2021-12-17) | 5.51% |
| 3 months (2021-10-15) | -13.60% |
| 6 months (2021-07-17) | 61.10% |
| 1 year (2021-01-15) | 176.91% |
|---|---|
| 2 years (2020-01-17) | 78.17% |
| 3 years (2019-01-17) | 146.69% |
| 5 years (2017-01-17) | 112.15% |
Valuing Tiptree stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tiptree's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tiptree's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Tiptree shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Tiptree's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $144.2 million.
The EBITDA is a measure of a Tiptree's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.1 billion |
|---|---|
| Operating margin TTM | 10.54% |
| Gross profit TTM | $297.6 million |
| Return on assets TTM | 2.44% |
| Return on equity TTM | 15.5% |
| Profit margin | 4.62% |
| Book value | $11.37 |
| Market capitalisation | $453.9 million |
TTM: trailing 12 months
Dividend payout ratio: 13.94% of net profits
Recently Tiptree has paid out, on average, around 13.94% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.19% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Tiptree shareholders could enjoy a 1.19% return on their shares, in the form of dividend payments. In Tiptree's case, that would currently equate to about $0.16 per share.
While Tiptree's payout ratio might seem low, this can signify that Tiptree is investing more in its future growth.
Tiptree's most recent dividend payout was on 28 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 18 November 2021 (the "ex-dividend date").
Tiptree's shares were split on a 3:2 basis on 13 September 2010. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Tiptree shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Tiptree shares which in turn could have impacted Tiptree's share price.
Over the last 12 months, Tiptree's shares have ranged in value from as little as $4.7483 up to $17.2538. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tiptree's is 1.1799. This would suggest that Tiptree's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Tiptree Inc. , through its subsidiaries, underwrites and administers specialty insurance products primarily in the United States. It operates in two segments, Insurance and Mortgage. The company provides niche commercial and personal lines insurance, credit insurance and collateral protection products, and warranty and service contract products and solutions, as well as premium finance services. It also offers mortgage loans for institutional investors; and maritime transportation services, as well as invests in securities and other assets. Tiptree Inc. markets its products through a network of independent insurance agents, consumer finance companies, auto dealers, retailers, brokers, and managing general agencies.
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.